GSK Investigational Site

Westerstede, Lower Saxony 26655

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, Depressive Disorder, Major, Social Phobia

Studies at this site

• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Clinical Study to Test a New Drug to Treat Major Depression — Completed
• Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
• Treatment Of Patients With Social Anxiety Disorder — Completed